Endometriosis Therapies Market Report

Global and China Endometriosis Therapies Industry Market Research Report (2017-2028)

  • POSTDATE：Dec 25, 2022
  • PAGES：168
  • REPORT CODE：GMM1492783
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Endometriosis is very painful and can lead to infertility. It affects the outline tissue of the uterus and causes internal bleeding and inflammation. The global endometriosis market size is expected to expand by 2025. Symptoms of endometriosis are, for example, pain before and during the menstrual period, pain during ovulation and irregular or massive bleeding over some time, resulting in a significant reduction in the working female population. High prevalence, unknown etiology, and high productivity loss are the main factors that have led many research institutions and drug manufacturers to research the best diagnosis and treatment of the disease.

    Gonadotropin-releasing hormone agonists, oral contraceptives, and progestin therapy are widely used for pain after diagnosis. The market share of non-steroidal anti-inflammatory drugs accounts for the major share of the global endometriosis market and is expected to maintain its dominant position. The supply of a large number of brands and generic products is expected to drive the growth of market segments soon.

    In developed and developing countries, the increase in the female population aged 15-49 years is expected to drive the growth of the endometriosis drug market. It is expected that the high prevalence of endometriosis among women of childbearing age will drive the market demand for endometriosis treatment in the next few years. The growth of the female population during childbearing age, women's awareness of this disease continues to increase, and the development of new drugs for the treatment of endometriosis are some of the factors that have contributed to market growth. However, it takes more than seven years to diagnose the disease, and the lack of non-invasive diagnostic tests will increase patient suffering. Therefore, this factor may inhibit the growth of the endometriosis therapy market. Also, many important manufacturers are conducting extensive research in the development of advanced drugs and treatments for endometriosis, taking into account cost management, and such initiatives will drive market growth.

    This report elaborates on the current development of the Endometriosis Therapies industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • AbbVie

    • Eli Lilly

    • AstraZeneca

    • Bayer

    • Astellas Pharma

    • Meditrina Pharmaceuticals

    • Pfizer

    • Neurocrine Biosciences

    • Takeda Pharmaceutical

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Hormonal Contraceptives

    • Gonadotropin-releasing Hormone (Gn-RH) Agonists

    • Progestin Therapy

    • Aromatase Inhibitors

    Application:

    • Hospital

    • Clinic

    • Other

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Endometriosis Therapies Industry Overview

      • 1.1.1 Endometriosis Therapies Market Scope and Market Segments

      • 1.1.2 Endometriosis Therapies Industry Characteristics

      • 1.1.3 Global and China Endometriosis Therapies Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Endometriosis Therapies Production Value and Growth Rate (2017-2028)

    • 1.2 Global Endometriosis Therapies Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Hormonal Contraceptives

      • 1.2.2 Gonadotropin-releasing Hormone (Gn-RH) Agonists

      • 1.2.3 Progestin Therapy

      • 1.2.4 Aromatase Inhibitors

    • 1.3 Global Endometriosis Therapies Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Hospital

      • 1.3.2 Clinic

      • 1.3.3 Other

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Endometriosis Therapies Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Endometriosis Therapies Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Endometriosis Therapies Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Endometriosis Therapies Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Endometriosis Therapies Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Endometriosis Therapies Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Endometriosis Therapies Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Endometriosis Therapies Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Endometriosis Therapies Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Endometriosis Therapies Industry Porter's Five Forces Model Analysis

      • 2.2.3 Endometriosis Therapies Industry PEST Analysis

    • 2.3 Endometriosis Therapies Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Endometriosis Therapies Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Endometriosis Therapies Industry

    Chapter 3 Global and China Endometriosis Therapies Market, by Manufacturer

    • 3.1 Global and China Endometriosis Therapies Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Endometriosis Therapies Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Endometriosis Therapies Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Endometriosis Therapies Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Endometriosis Therapies Market Top 3 Players

    Chapter 4 Global and China Endometriosis Therapies Market, by Type (2017-2028)

    • 4.1 Endometriosis Therapies Market Trend, by Type

    • 4.2 Global Endometriosis Therapies Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Endometriosis Therapies Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Endometriosis Therapies Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Endometriosis Therapies Price Trend, by Type (2017-2028)

    • 4.3 China Endometriosis Therapies Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Endometriosis Therapies Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Endometriosis Therapies Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Endometriosis Therapies Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Endometriosis Therapies Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Endometriosis Therapies Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Endometriosis Therapies Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Endometriosis Therapies Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Endometriosis Therapies Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Endometriosis Therapies Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Endometriosis Therapies Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Endometriosis Therapies Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Endometriosis Therapies Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Endometriosis Therapies Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Endometriosis Therapies Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Endometriosis Therapies Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Endometriosis Therapies Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Endometriosis Therapies Market Analysis

    • 7.1 North America Endometriosis Therapies Market, by Type

    • 7.2 North America Endometriosis Therapies Market, by Application

    • 7.3 North America Endometriosis Therapies Market Analysis and Forecast, by Country

      • 7.3.1 United States Endometriosis Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Endometriosis Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Endometriosis Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Endometriosis Therapies Market Analysis

    • 8.1 Europe Endometriosis Therapies Market, by Type

    • 8.2 Europe Endometriosis Therapies Market, by Application

    • 8.3 Europe Endometriosis Therapies Market Analysis and Forecast, by Country

      • 8.3.1 Germany Endometriosis Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Endometriosis Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Endometriosis Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Endometriosis Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Endometriosis Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Endometriosis Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Endometriosis Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Endometriosis Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Endometriosis Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Endometriosis Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Endometriosis Therapies Market Analysis

    • 9.1 APAC Endometriosis Therapies Market, by Type

    • 9.2 APAC Endometriosis Therapies Market, by Application

    • 9.3 APAC Endometriosis Therapies Market Analysis and Forecast, by Country

      • 9.3.1 China Endometriosis Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Endometriosis Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Endometriosis Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Endometriosis Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Endometriosis Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Endometriosis Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Endometriosis Therapies Market Analysis

    • 10.1 Latin America, Middle East and Africa Endometriosis Therapies Market, by Type

    • 10.2 Latin America, Middle East and Africa Endometriosis Therapies Market, by Application

    • 10.3 Latin America, Middle East and Africa Endometriosis Therapies Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Endometriosis Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Endometriosis Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Endometriosis Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Endometriosis Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Endometriosis Therapies Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Endometriosis Therapies Company Profiles

      • 11.1 AbbVie

        • 11.1.1 AbbVie Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 AbbVie Endometriosis Therapies Product Profiles, Application and Specification

        • 11.1.3 AbbVie Endometriosis Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Eli Lilly

        • 11.2.1 Eli Lilly Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Eli Lilly Endometriosis Therapies Product Profiles, Application and Specification

        • 11.2.3 Eli Lilly Endometriosis Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 AstraZeneca

        • 11.3.1 AstraZeneca Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 AstraZeneca Endometriosis Therapies Product Profiles, Application and Specification

        • 11.3.3 AstraZeneca Endometriosis Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Bayer

        • 11.4.1 Bayer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Bayer Endometriosis Therapies Product Profiles, Application and Specification

        • 11.4.3 Bayer Endometriosis Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Astellas Pharma

        • 11.5.1 Astellas Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Astellas Pharma Endometriosis Therapies Product Profiles, Application and Specification

        • 11.5.3 Astellas Pharma Endometriosis Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Meditrina Pharmaceuticals

        • 11.6.1 Meditrina Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Meditrina Pharmaceuticals Endometriosis Therapies Product Profiles, Application and Specification

        • 11.6.3 Meditrina Pharmaceuticals Endometriosis Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Pfizer

        • 11.7.1 Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Pfizer Endometriosis Therapies Product Profiles, Application and Specification

        • 11.7.3 Pfizer Endometriosis Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Neurocrine Biosciences

        • 11.8.1 Neurocrine Biosciences Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Neurocrine Biosciences Endometriosis Therapies Product Profiles, Application and Specification

        • 11.8.3 Neurocrine Biosciences Endometriosis Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Takeda Pharmaceutical

        • 11.9.1 Takeda Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Takeda Pharmaceutical Endometriosis Therapies Product Profiles, Application and Specification

        • 11.9.3 Takeda Pharmaceutical Endometriosis Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Endometriosis Therapies Industry Investment Prospect and Risk Assessment

    • 12.1 Endometriosis Therapies Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Endometriosis Therapies Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Endometriosis Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure China Endometriosis Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure Global Endometriosis Therapies Production Value and Growth Rate (2017-2028)

    • Figure China Endometriosis Therapies Production Value and Growth Rate (2017-2028)

    • Figure Global Endometriosis Therapies Market Size and Growth Rate of Hormonal Contraceptives (2017-2028)

    • Figure Global Endometriosis Therapies Market Size and Growth Rate of Gonadotropin-releasing Hormone (Gn-RH) Agonists (2017-2028)

    • Figure Global Endometriosis Therapies Market Size and Growth Rate of Progestin Therapy (2017-2028)

    • Figure Global Endometriosis Therapies Market Size and Growth Rate of Aromatase Inhibitors (2017-2028)

    • Figure Global Endometriosis Therapies Market Size and Growth Rate of Hospital (2017-2028)

    • Figure Global Endometriosis Therapies Market Size and Growth Rate of Clinic (2017-2028)

    • Figure Global Endometriosis Therapies Market Size and Growth Rate of Other (2017-2028)

    • Figure North America Endometriosis Therapies Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Endometriosis Therapies Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Endometriosis Therapies Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Endometriosis Therapies Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Endometriosis Therapies Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Endometriosis Therapies Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Endometriosis Therapies Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Endometriosis Therapies Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Endometriosis Therapies Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Endometriosis Therapies Market Share, by Manufacturer in 2021

    • Figure Global and China Endometriosis Therapies Market Share, by Manufacturer in 2022

    • Table Global Endometriosis Therapies Sales Volume, by Type (2017-2028)

    • Table Global Endometriosis Therapies Sales Volume Share, by Type (2017-2028)

    • Figure Global Endometriosis Therapies Sales Volume Share, by Type (2017-2028)

    • Table Global Endometriosis Therapies Sales Value, by Type (2017-2028)

    • Table Global Endometriosis Therapies Sales Value Share, by Type (2017-2028)

    • Figure Global Endometriosis Therapies Price Trend, by Type (2017-2028)

    • Table China Endometriosis Therapies Sales Volume, by Type (2017-2028)

    • Table China Endometriosis Therapies Sales Volume Share, by Type (2017-2028)

    • Figure China Endometriosis Therapies Sales Volume Share, by Type (2017-2028)

    • Table China Endometriosis Therapies Sales Value, by Type (2017-2028)

    • Table China Endometriosis Therapies Sales Value Share, by Type (2017-2028)

    • Figure China Endometriosis Therapies Price Trend, by Type (2017-2028)

    • Table Global Endometriosis Therapies Sales Volume, by Application (2017-2028)

    • Table Global Endometriosis Therapies Sales Volume Share, by Application (2017-2028)

    • Figure Global Endometriosis Therapies Sales Volume Share, by Application (2017-2028)

    • Table Global Endometriosis Therapies Sales Value, by Application (2017-2028)

    • Table Global Endometriosis Therapies Sales Value Share, by Application (2017-2028)

    • Figure Global Endometriosis Therapies Sales Value Share, by Application (2017-2028)

    • Table China Endometriosis Therapies Sales Volume, by Application (2017-2028)

    • Table China Endometriosis Therapies Sales Volume Share, by Application (2017-2028)

    • Figure China Endometriosis Therapies Sales Volume Share, by Application (2017-2028)

    • Table China Endometriosis Therapies Sales Value, by Application (2017-2028)

    • Table China Endometriosis Therapies Sales Value Share, by Application (2017-2028)

    • Figure China Endometriosis Therapies Sales Value Share, by Application (2017-2028)

    • Figure China Endometriosis Therapies Production, Import, Consumption and Export (2017-2022)

    • Figure North America Endometriosis Therapies Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Endometriosis Therapies Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Endometriosis Therapies Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Endometriosis Therapies Production, Import, Consumption and Export (2017-2022)

    • Table North America Endometriosis Therapies Sales Volume, by Type (2017-2028)

    • Table North America Endometriosis Therapies Sales Volume Share, by Type (2017-2028)

    • Figure North America Endometriosis Therapies Sales Volume Share, by Type (2017-2028)

    • Table North America Endometriosis Therapies Sales Volume, by Application (2017-2028)

    • Table North America Endometriosis Therapies Sales Volume Share, by Application (2017-2028)

    • Figure North America Endometriosis Therapies Sales Volume Share, by Application (2017-2028)

    • Figure United States Endometriosis Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure United States Endometriosis Therapies Sales Value and Growth Rate (2017-2028)

    • Figure Canada Endometriosis Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Endometriosis Therapies Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Endometriosis Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Endometriosis Therapies Sales Value and Growth Rate (2017-2028)

    • Table Europe Endometriosis Therapies Sales Volume, by Type (2017-2028)

    • Table Europe Endometriosis Therapies Sales Volume Share, by Type (2017-2028)

    • Figure Europe Endometriosis Therapies Sales Volume Share, by Type (2017-2028)

    • Table Europe Endometriosis Therapies Sales Volume, by Application (2017-2028)

    • Table Europe Endometriosis Therapies Sales Volume Share, by Application (2017-2028)

    • Figure Europe Endometriosis Therapies Sales Volume Share, by Application (2017-2028)

    • Figure Germany Endometriosis Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Endometriosis Therapies Sales Value and Growth Rate (2017-2028)

    • Figure UK Endometriosis Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure UK Endometriosis Therapies Sales Value and Growth Rate (2017-2028)

    • Figure France Endometriosis Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure France Endometriosis Therapies Sales Value and Growth Rate (2017-2028)

    • Figure Italy Endometriosis Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Endometriosis Therapies Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Endometriosis Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Endometriosis Therapies Sales Value and Growth Rate (2017-2028)

    • Figure Spain Endometriosis Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Endometriosis Therapies Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Endometriosis Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Endometriosis Therapies Sales Value and Growth Rate (2017-2028)

    • Figure Poland Endometriosis Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Endometriosis Therapies Sales Value and Growth Rate (2017-2028)

    • Figure Russia Endometriosis Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Endometriosis Therapies Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Endometriosis Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Endometriosis Therapies Sales Value and Growth Rate (2017-2028)

    • Table APAC Endometriosis Therapies Sales Volume, by Type (2017-2028)

    • Table APAC Endometriosis Therapies Sales Volume Share, by Type (2017-2028)

    • Figure APAC Endometriosis Therapies Sales Volume Share, by Type (2017-2028)

    • Table APAC Endometriosis Therapies Sales Volume, by Application (2017-2028)

    • Table APAC Endometriosis Therapies Sales Volume Share, by Application (2017-2028)

    • Figure APAC Endometriosis Therapies Sales Volume Share, by Application (2017-2028)

    • Figure China Endometriosis Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure China Endometriosis Therapies Sales Value and Growth Rate (2017-2028)

    • Figure Japan Endometriosis Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Endometriosis Therapies Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Endometriosis Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Endometriosis Therapies Sales Value and Growth Rate (2017-2028)

    • Figure India Endometriosis Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure India Endometriosis Therapies Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Endometriosis Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Endometriosis Therapies Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Endometriosis Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Endometriosis Therapies Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Endometriosis Therapies Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Endometriosis Therapies Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Endometriosis Therapies Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Endometriosis Therapies Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Endometriosis Therapies Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Endometriosis Therapies Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Endometriosis Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Endometriosis Therapies Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Endometriosis Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Endometriosis Therapies Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Endometriosis Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Endometriosis Therapies Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Endometriosis Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Endometriosis Therapies Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Endometriosis Therapies Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Endometriosis Therapies Sales Value and Growth Rate (2017-2028)

    • Table AbbVie Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table AbbVie Product Profiles, Application and Specification

    • Table AbbVie Endometriosis Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Eli Lilly Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Eli Lilly Product Profiles, Application and Specification

    • Table Eli Lilly Endometriosis Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table AstraZeneca Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table AstraZeneca Product Profiles, Application and Specification

    • Table AstraZeneca Endometriosis Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Bayer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Bayer Product Profiles, Application and Specification

    • Table Bayer Endometriosis Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Astellas Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Astellas Pharma Product Profiles, Application and Specification

    • Table Astellas Pharma Endometriosis Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Meditrina Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Meditrina Pharmaceuticals Product Profiles, Application and Specification

    • Table Meditrina Pharmaceuticals Endometriosis Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Pfizer Product Profiles, Application and Specification

    • Table Pfizer Endometriosis Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Neurocrine Biosciences Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Neurocrine Biosciences Product Profiles, Application and Specification

    • Table Neurocrine Biosciences Endometriosis Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Takeda Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Takeda Pharmaceutical Product Profiles, Application and Specification

    • Table Takeda Pharmaceutical Endometriosis Therapies Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US